You have 9 free searches left this month | for more free features.

GS-5885

Showing 1 - 25 of 311

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],

Completed
  • Hepatitis B
  • Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
  • +2 more
  • Baltimore, Maryland
    Institute of Human Virology (IHV), University of Maryland Baltim
Aug 24, 2021

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

Terminated
  • Hepatitis C Virus Infection
  • Sofosbuvir (SOF)
  • +3 more
  • Phoenix, Arizona
  • +50 more
Jan 25, 2023

Hepatitis C Virus Infection Trial in Cairo (LDV/SOF)

Completed
  • Hepatitis C Virus Infection
  • Cairo, Egypt
    National Cancer Institute, Cairo University
Feb 18, 2020

Hepatitis C Virus Infection Trial in Taiwan (LDV/SOF)

Completed
  • Hepatitis C Virus Infection
  • Changhua, Taiwan
  • +10 more
Feb 18, 2020

Harvoni in Chronic Hepatitis C Virus (HCV) Infection in Korea

Completed
  • Hepatitis C Virus
  • Seongnam-si, Gyeonggido, Korea, Republic of
  • +71 more
Nov 24, 2021

Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF, RBV)

Completed
  • Hepatitis C Virus Infection
  • Birmingham, Alabama
  • +30 more
Feb 18, 2020

Chronic HCV Infection Trial in China, Korea, Republic of, Taiwan (LDV/SOF)

Completed
  • Chronic HCV Infection
  • Beijing, China
  • +44 more
Feb 18, 2020

Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF)

Completed
  • Hepatitis C Virus Infection
  • Boston, Massachusetts
  • +20 more
Feb 18, 2020

Chronic HCV Infection Trial in San Antonio (LDV/SOF, RBV, GS-9669)

Completed
  • Chronic HCV Infection
  • San Antonio, Texas
    (unnamed)
Oct 19, 2018

Hepatitis C Trial in Boston (LDV/SOF)

Completed
  • Hepatitis C
  • Boston, Massachusetts
    (unnamed)
Oct 19, 2018

Chronic Hepatitis C Trial in Auckland, Christchurch (LDV/SOF, RBV, SOF/VEL)

Completed
  • Chronic Hepatitis C
  • Auckland, New Zealand
  • +1 more
Oct 19, 2018

Hepatitis C Virus Infection Trial in San Antonio (LDV/SOF, VDV, RBV)

Completed
  • Hepatitis C Virus Infection
  • San Antonio, Texas
    (unnamed)
Oct 19, 2018

Hepatitis C Virus Infection Trial in Lutherville (LDV/SOF)

Completed
  • Hepatitis C Virus Infection
  • Lutherville, Maryland
    (unnamed)
Oct 19, 2018

Chronic Hepatitis C Trial in Auckland, Christchurch (LDV/SOF, SOF, RBV)

Completed
  • Chronic Hepatitis C
  • Auckland, New Zealand
  • +1 more
Oct 19, 2018

Chronic Hepatitis C Virus Trial in San Antonio (LDV/SOF, RBV)

Completed
  • Chronic Hepatitis C Virus
  • San Antonio, Texas
    (unnamed)
Oct 19, 2018

Hepatitis C Virus Infection Trial in Boston (LDV/SOF, Placebo)

Completed
  • Hepatitis C Virus Infection
  • Boston, Massachusetts
    (unnamed)
Oct 19, 2018

Hepatitis C Virus Infection Trial in Cairo, Mansourah, Shibin Al Kawm (LDV/SOF, RBV)

Completed
  • Hepatitis C Virus Infection
  • Cairo, Egypt
  • +3 more
Oct 19, 2018

Chronic Genotype 4 HCV, Chronic Genotype 5 HCV Trial in France (LDV/SOF)

Completed
  • Chronic Genotype 4 HCV
  • Chronic Genotype 5 HCV
  • Clermont Ferrand, France
  • +4 more
Oct 19, 2018

Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF)

Completed
  • Hepatitis C Virus Infection
  • Wien, Austria
  • +4 more
Oct 19, 2018

Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Sep 4, 2023

Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))

Enrolling by invitation
  • Alcohol Consumption
  • Control
  • +2 more
  • Palo Alto, California
    Stanford University
May 8, 2023

Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

Not yet recruiting
  • Chronic Hepatitis B
  • GS-2829
  • +3 more
  • (no location specified)
Mar 14, 2023

Hepatitis C Virus Infection Trial in United States (LDV/SOF)

Completed
  • Hepatitis C Virus Infection
  • San Francisco, California
  • +5 more
Oct 19, 2018

Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))

Not yet recruiting
  • Genetic Predisposition
  • Next-Generation Sequencing (NGS)
  • Tübingen, Germany
    University Hospital Tübingen
Sep 22, 2023